Written informed consent from this patient was obtained, and this study was approved by the institutional review board of the Chang Gung Memorial Hospital. We obtained institutional written consent ...

A University of Colorado Cancer Center study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) draws a line from mutation of the gene NTRK1, to its role as ...

Prevalence of new genetic driver in lung cancer shown in study Date: May 31, 2014 Source: University of Colorado Cancer Center Summary: A line has been drawn from mutation of the gene NTRK1, to ...

NTRK1 had been identified as a driver of thyroid cancer and so was included in the panel (though drug development had stalled due in part to the relative rarity of the thyroid disease).

To the list of oncogenic drivers of lung cancer that includes ALK, EGFR, ROS1 and RET, results of a University of Colorado Cancer Center study presented at ASCO 2013 show that mutations in the ...

Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 Pembrolizumab The following represents disclosure ...